Company profile: Coherex Medical
1.1 - Company Overview
Company description
- Provider of medical devices addressing structural heart disease, including a patent foramen ovale (PFO) closure system designed to stimulate tissue in-growth for long-term closure, and the WaveCrest Left Atrial Appendage Occlusion System to close the left atrial appendage and reduce stroke risk in atrial fibrillation patients who cannot tolerate chronic oral anticoagulation therapy.
Products and services
- Structural Heart Medical Device Development & Commercialization: Structural-heart-focused service that develops and commercializes medical devices addressing structural heart disease conditions
- Patent Foramen Ovale (PFO) Closure System: Tissue-integrating device engineered to stimulate tissue in-growth, achieving durable, long-term closure of the PFO for structural heart disease management
- WaveCrest Left Atrial Appendage Occlusion System: Occlusion-based system engineered to close the left atrial appendage, lowering stroke risk in atrial fibrillation patients intolerant to chronic oral anticoagulation therapy
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Coherex Medical
Cardiol Therapeutics
HQ: Canada
Website
- Description: Provider of cannabidiol-based therapies for heart disease, including CardiolRx, an oral solution in clinical development to inhibit inflammatory pathways; CRD-38, a subcutaneous formulation for heart failure aiming to improve pharmacokinetics and therapeutic efficacy; and Phase II studies MAvERIC-Pilot (recurrent pericarditis) and ARCHER (acute myocarditis) evaluating safety, tolerability, efficacy, and impact on myocardial recovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cardiol Therapeutics company profile →
Gemphire Therapeutics
HQ: United States
Website
- Description: Provider of Gemcabene, an LDL cholesterol-lowering medication, which it manufactures and markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gemphire Therapeutics company profile →
HeartIT
HQ: United States
Website
- Description: Provider of medical image viewing and reporting software, offering a browser-based workflow solution that integrates EMR via HL7 messaging and enables image sharing with referring physicians.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HeartIT company profile →
VerAvanti
HQ: United States
Website
- Description: Provider of single-use intravascular endoscopic technologies, including a Scanning Fiber Endoscope delivering real-time, high-resolution images of intravascular anatomy to help diagnose and treat stroke and cardiovascular events; in-house MEMS manufacturing of micro-small components using precise robotics and cleanroom assembly; and O-pH imaging to measure oral biofilm acidity to predict and manage tooth decay.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full VerAvanti company profile →
Vascular Concepts
HQ: India
Website
- Description: Provider of cutting-edge medical devices for the treatment of arterial diseases that are affordable for the common man.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vascular Concepts company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Coherex Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Coherex Medical
2.2 - Growth funds investing in similar companies to Coherex Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Coherex Medical
4.2 - Public trading comparable groups for Coherex Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →